{"created":"2023-05-15T14:19:25.581630+00:00","id":3513,"links":{},"metadata":{"_buckets":{"deposit":"64218271-7342-48ec-8524-eee888431da9"},"_deposit":{"created_by":3,"id":"3513","owners":[3],"pid":{"revision_id":0,"type":"depid","value":"3513"},"status":"published"},"_oai":{"id":"oai:ohu-lib.repo.nii.ac.jp:00003513","sets":["90:210:216"]},"author_link":["11940","11939"],"item_10002_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2009-12","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"Suppl.","bibliographicPageStart":"S13","bibliographicVolumeNumber":"36巻","bibliographic_titles":[{"bibliographic_title":"奥羽大学歯学誌"}]}]},"item_10002_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0916-2313","subitem_source_identifier_type":"ISSN"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Abe, Masatoshi"}],"nameIdentifiers":[{"nameIdentifier":"11939","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Horiuchi, Noboru"}],"nameIdentifiers":[{"nameIdentifier":"11940","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2014-05-16"}],"displaytype":"detail","filename":"36(sup)S13.pdf","filesize":[{"value":"696.0 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"36(sup)S13.pdf","url":"https://ohu-lib.repo.nii.ac.jp/record/3513/files/36(sup)S13.pdf"},"version_id":"7f482185-d347-4a70-9384-38546ba76d99"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"*Boronic Acids(治療的利用,薬理学); NF-Kappa B; *Oligopeptides(治療的利用,薬理学); Protease Inhibitors(治療的利用,薬理学); *U-Plasminogen Activator(拮抗物質・阻害物質); *口腔腫瘍(実験的,予防); 抗腫瘍剤(治療的利用); *扁平上皮癌(実験的,予防); 腫瘍細胞系","subitem_subject_scheme":"Other"},{"subitem_subject":"*Epoxomicin(治療的利用,薬理学); Proteasome Inhibitors(治療的利用,薬理学); *MG-262(治療的利用,薬理学)","subitem_subject_scheme":"Other"},{"subitem_subject":"ヒト; 歯学","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"departmental bulletin paper","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"The Proteasome Inhibitors Epoxomicin and MG262 Suppress Urokinase-Type Plasminogen Activator Expression by Human Oral Squamous Carcinoma Cells (HSC-3)","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"The Proteasome Inhibitors Epoxomicin and MG262 Suppress Urokinase-Type Plasminogen Activator Expression by Human Oral Squamous Carcinoma Cells (HSC-3)","subitem_title_language":"en"}]},"item_type_id":"10002","owner":"3","path":["216"],"pubdate":{"attribute_name":"公開日","attribute_value":"2014-05-16"},"publish_date":"2014-05-16","publish_status":"0","recid":"3513","relation_version_is_last":true,"title":["The Proteasome Inhibitors Epoxomicin and MG262 Suppress Urokinase-Type Plasminogen Activator Expression by Human Oral Squamous Carcinoma Cells (HSC-3)"],"weko_creator_id":"3","weko_shared_id":-1},"updated":"2023-05-15T18:27:31.268964+00:00"}